H.R. 7693 119th Congress House

Leo’s Law

Official title: To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.

Introduced: February 25, 2026 Introduced by: Josh Gottheimer Democratic · New Jersey See on congress.gov

Health

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 25, 2026

Introduced in House

Feb 25, 2026

Referred to the House Committee on Energy and Commerce.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now February 25, 2026

Referred to the House Committee on Energy and Commerce.

Plain-English summary Congressional Research Service

Leo's Law

This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.

Bill text 1 version